Noncoding RNAs: Key Modulators of the Hippo Pathway in Hepatocellular Carcinoma Progression
Journal of Cancer Biomoleculars and Therapeutics · 2025
DOI: 10.62382/jcbt.v2i1.36 ↗Abstract
The Hippo signaling system plays a vital role in controlling cell proliferation, apoptosis, and organ size. Disruption of this pathway strongly correlates with the growth and progression of hepatocellular carcinoma (HCC). Noncoding RNAs (ncRNAs), including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), play a crucial role in regulating Hippo signaling and have a significant impact on different aspects of liver tumor development. This paper thoroughly investigates the functions of ncRNAs in regulating the Hippo pathway, specifically in liver cancer. We examine how certain miRNAs and lncRNAs engage with Hippo signaling components, influencing cellular processes like growth regulation, programmed cell death, the spread of cancer cells, and resistance to chemotherapy. Developing an understanding of these interactions offers valuable knowledge about the intricate regulatory networks that control liver cancer and identifies possible targets for therapeutic intervention. Our study shows how important it is for ncRNA to control Hippo signaling in liver cancer. It also suggests possible directions for future research that focuses on creating ncRNA-based diagnostic and therapeutic methods.
EUVIMED